Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Study of Initial Ozurdex (Dexamethasone Implant) Versus Avastin (Bevacizumab) in the Treatment of Macular Edema Following Central Retinal Vein Occlusion (CRVO)

NCT01231633 is registered in ClinicalTrials.gov with Long Island Vitreoretinal Consultants as lead sponsor.

NCT NCT01231633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01231633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Study of Initial Ozurdex (Dexamethasone Implant) Versus Avastin (Bevacizumab) in the Treatment of Macular Edema Following Central Retinal Vein Occlusion (CRVO)
Lead sponsor
Long Island Vitreoretinal Consultants
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2010
Completion date
September 30, 2014
Enrollment
27 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

central retinal vein occlusion, macular edema